secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001104659-23-025048
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences prices $20M public offering of common stock and warrants
-----------------------------------------------------------------------------

- 7,220,217 shares and warrants at $2.77/unit; gross proceeds $20M.
- Net proceeds ~$18.5M after underwriting discounts and offering expenses.
- Warrants exercisable at $2.77/share, immediately exercisable, expire in 5 years.
- Company reduces exercise price of 3,438,851 existing warrants to $3.62.
- Offering expected to close on February 28, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465923025048/0001104659-23-025048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465923025048/tm237769d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-025048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer